Two Sealed Airtight Medical Vials Against Bright Background Front View. Real-world data conflict with a recent meta-analysis including patients from highly selected clinical trial populations.
Reports suggest that at least 25% of ovarian disorders are due to dysfunction of the brain mechanism in the hypothalamus that controls the gonadotropin-releasing hormone (GnRH), which is a molecule ...
NEW ORLEANS -- Off-label use of oral elagolix (Orilissa) may be a more patient-friendly alternative to standard-of-care injectable GnRH antagonists for ovulation suppression during in vitro ...
In 1977, the Nobel Prize in Physiology or Medicine was awarded to Roger Guillemin and Andrew Schally for their discovery and synthesis of gonadotropin-releasing hormone (GnRH), a key regulator of ...
Gonadotropin-releasing hormone (GnRH) therapy improves cognitive function in Down syndrome (DS) mouse models and male patients with DS, according to a new study. The findings reveal a previously ...
FP-001 42 mg is an investigational, sustained-release formulation of a GnRH agonist being developed for the treatment of CPP. It is designed to provide continuous suppression of gonadotropin secretion ...
Please provide your email address to receive an email when new articles are posted on . “Many transgender boys do not want to compromise their adult height,” Sabine E. Hannema, MD, PhD, a pediatric ...
Endometriosis is a lifelong condition so it is important to develop a plan to manage it based on the extent of the disease, severity of pain and potential plans for pregnancy. Since it is a chronic ...
If you're having infertility issues, your doctor may prescribe medicine to help you get pregnant. These meds, called fertility drugs, work by causing your body to release hormones that trigger or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback